Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENFORTUMAB VEDOTIN-EJFV Cause Transaminases increased? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Transaminases increased have been filed in association with ENFORTUMAB VEDOTIN-EJFV. This represents 0.3% of all adverse event reports for ENFORTUMAB VEDOTIN-EJFV.

12
Reports of Transaminases increased with ENFORTUMAB VEDOTIN-EJFV
0.3%
of all ENFORTUMAB VEDOTIN-EJFV reports
0
Deaths
6
Hospitalizations

How Dangerous Is Transaminases increased From ENFORTUMAB VEDOTIN-EJFV?

Of the 12 reports, 6 (50.0%) required hospitalization.

Is Transaminases increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN-EJFV. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does ENFORTUMAB VEDOTIN-EJFV Cause?

Rash (560) Malignant neoplasm progression (410) Neuropathy peripheral (410) Fatigue (281) Pruritus (260) Diarrhoea (257) Death (238) Decreased appetite (230) Off label use (193) Alopecia (185)

What Other Drugs Cause Transaminases increased?

METHOTREXATE (1,236) ACETAMINOPHEN (929) ATORVASTATIN (472) RITUXIMAB (448) CYCLOPHOSPHAMIDE (401) PREDNISONE (362) ADALIMUMAB (340) PACLITAXEL (333) ROSUVASTATIN (324) CARBOPLATIN (319)

Which ENFORTUMAB VEDOTIN-EJFV Alternatives Have Lower Transaminases increased Risk?

ENFORTUMAB VEDOTIN-EJFV vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV ENFORTUMAB VEDOTIN-EJFV vs ENFUVIRTIDE ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN - WINTHROP ENFORTUMAB VEDOTIN-EJFV vs ENSIFENTRINE

Related Pages

ENFORTUMAB VEDOTIN-EJFV Full Profile All Transaminases increased Reports All Drugs Causing Transaminases increased ENFORTUMAB VEDOTIN-EJFV Demographics